Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Biomaterials. 2015 Dec 2;80:11–19. doi: 10.1016/j.biomaterials.2015.11.065

Fig 3. MHCII and cytokine expression within TGF-β1 scaffolds.

Fig 3

(A) MHCII expression on leukocytes within scaffolds containing a dose range of TGF-β1 collected seven days after implant. Data is from 8 scaffolds per condition isolated from 4 mice receiving bilateral scaffold implants into the epididymal fat pads. * indicates P < 0.05 versus 0 μg. ** indicates P < 0.05 versus 0.2 μg. Statistics determined by one-way ANOVA with Tukey’s Multiple Comparison Test. (B) Cytokines detected by ELISA in scaffold homogenate collected three days after implant. Data is from 10 scaffolds isolated from 5 mice per condition receiving bilateral scaffold implants into the epididymal fat pads. * indicates P < 0.05 versus 0.0 μg. Statistics determined by unpaired t-test.